UF Innovate | Sid Martin Biotech alum RTI Surgical Holdings, Inc., a global surgical implant company, will showcase its expanding body of clinical data on the SImmetry Sacroiliac Joint Fusion System at the 2020 International Society for the Advancement of Spine Surgery (ISASS) meeting in San Juan, Puerto Rico, from February 26 – 28, 2020. The interim results on 50 patients at 24 months in the EVoluSIon study indicate 98 percent of treated joints show evidence of fusion and 78 percent of patients are opioid-free, reinforcing the importance of decortication as part of the SImmetry System procedure to drive fusion and pain relief for patients with SI joint dysfunction.
“In my experience using the SImmetry System, I have observed it follows true orthopedic principles for fusion with decortication, bone grafting, and fixation,” said Dr. Donald Kucharzyk of DK Orthopedics in Crown Point, Indiana. “It is reproducible and consistent in its technique case after case, even with anatomic variations. Patients feel the difference immediately. These interim EVoluSIon study results reveal a significant reduction in opioid use from baseline, significant improvements in activity levels, and compared to the previous literature published, compelling evidence of fusion.”Learn more about RTI Surgical Releases Data on the SImmetry System Showing 98% of Treated SI Joints Demonstrate Evidence of Fusion.